Abstract
Graft-versus-host disease (GVHD) remains a major complication of allogeneic hematopoietic stem cell transplantation. Polymyositis can occur in association with chronic GVHD and mimics the idiopathic form of the disease. We report two cases of chronic GVHD-associated polymyositis and review the published literature. The two patients presented 13 and 19 months after allogeneic transplantation with characteristic features of muscular hypotrophy, proximal muscle weakness, pain, elevated creatine phosphokinase (CPK), aldolase and SGPT. Interestingly, both patients had HLA DR52 genes, which is frequently reported in association with idiopathic polymyositis. Electromyogram (EMG) and muscle biopsy confirmed the diagnosis. Treatment with cyclosporine or tacrolimus resulted in complete and sustained remission of polymyositis in both cases. A review of the literature shows cyclosporine and steroids are well-described treatment options for patients with myositis in post transplant, as well as idiopathic cases. The duration of immunosuppressive treatment has varied in different reports, and there is a risk of recurrence when immunosuppression is tapered.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ferrara JL, Deeg HJ . Graft-versus-host disease New Engl J Med 1991 324: 667 674
Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression Blood 1981 57: 267 276
Vogelsang GB, Wagner JE . Graft-versus-host disease Hematol Oncol Clin North Am 1990 4: 625 640
Korngold R, Sprent J . T-cell subsets and graft-versus-host disease Transplantation 1987 44: 335 339
Diamond D, Chang K, Jenkins K, Forman S . Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation Transplantation 1995 59: 1436 1444
Chosidow O, Bagot M, Vernant J-P et al. Sclerodermatous chronic graft-versus-host disease J Am Acad Dermatol 1992 26: 49 55
Ameen M, Russell-Jones R . Macroscopic and microscopic mucinosis in chronic sclerodermoid graft-versus-host disease Br J Dermatol 2000 142: 529 532
Lawley TJ, Peck GL, Moutsopoulos HM et al. Scleroderma, Sjogren-like syndrome, and chronic graft-versus-host disease Ann Intern Med 1977 87: 707 709
Rocha EM, Pelegrino FSA, De Paiva CS et al. GVHD dry eyes treated with autologous serum tears Bone Marrow Transplant 2000 25: 1101 1103
Rouquette-Gally AM, Boyeldieu D, Gluckman E et al. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma Br J Haematol 1987 66: 45 47
Parker P, Chao NJ, Ben-Ezra J et al. Polymyositis as a manifestation of chronic graft-versus-host disease Medicine 1996 75: 279 285
Parker P, Openshaw H, Forman SJ . Myositis associated with graft-versus-host disease Curr Opin Rheumatol 1997 9: 513 519
Prussick R, Brain MC, Walker IR, Sauder DN . Polymyositis: a manifestation of chronic graft-versus-host disease J Am Acad Dermatol 1991 25: 560 562
Leano AM, Miller K, White AC . Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant Bone Marrow Transplant 2000 26: 1117 1120
Biju G, Debashis D, Mammen C et al. Polymyositis – an unusual manifestation of chronic GVHD Rheumatol Int 2001 20: 169 170
Anderson B, Young V, Kean W et al. Polymyositis in chronic GVHD Arch Neurol 1982 39: 188 190
Nelson K, McQuillen M . Neurologic complications of GVHD Neurol Clin 1988 6: 389 403
Urbano-Marquez A, Estruch R, Grau JM et al. Inflammatory myopathy associated with chronic GVHD Neurology 1986 36: 1091 1093
Ascensao J, Mascarenhas RB, Mittleman A, Ahmed T . Case report: acute polymyositis in a patient with chronic GVHD Med Oncol Tumor Pharmacother 1992 9: 149 150
Silverstein L, Davies A, Kelsey S et al. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic GVHD after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion Bone Marrow Transplant 2001 27: 231 233
Reyes M, Noronha P, Thomas W, Heredia R . Myositis of chronic GVHD Neurology 1983 33: 1222 1224
Pier N, Dubowitz V . Chronic GVHD presenting with polymyositis Br Med J 1983 286: 2024
Tse S, Saunders EF, Silverman E et al. Myasthenia gravis and polymyositis as manifestations of chronic GVHD Bone Marrow Transplant 1999 23: 397 399
Blanche P, Dreyfus F, Sicard D . Polymyositis and chronic GVHD: efficacy of intravenous gammaglobulin and methotrexate Clin Exp Rheumatol 1995 13: 377 379
Slatkin NE, Sheibani K, Forman SJ et al. Myositis as the mayor manifestation of chronic GVHD Neurology 1987 205: (Suppl.) 183
Adams C, August CS, Maguire H, Sladky JT . Neuromuscular complications of bone marrow transplantation Pediatr Neurol 1995 12: 58 61
Hanslik T, Jaccard A, Guillon JM et al. Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin J Am Acad Dermatol 1993 28: 492 493
Oddis CV, Sciurba FC, Elmagd KA, Starzl TE . Tacrolimus in refractory polymyositis with interstitial lung disease Lancet 1999 353: 1762 1763
Love LA, Leff RL, Fraser DD et al. A new approach to the useful classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define homogeneous patient groups Medicine 1991 70: 360 374
Targoff IN . Immune manifestations of inflammatory muscle diseases Rh Dis Clin North Am 1994 20: 857 880
Goldstein R, Duvic M, Targoff IN et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis Arthritis Rheum 1990 33: 1240 1248
Jacobson P, Uberti J, Davis W, Ratantharathorn V . Tacrolimus: a new agent for the prevention of GVHD in hematopoietic stem cell transplantation Bone Marrow Transplant 1998 22: 217 225
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Couriel, D., Beguelin, G., Giralt, S. et al. Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 30, 543–546 (2002). https://doi.org/10.1038/sj.bmt.1703711
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703711
Keywords
This article is cited by
-
Clinical Characteristics of Myositis Associated with Graft-Versus-Host Disease
Current Rheumatology Reports (2021)
-
A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis
International Journal of Hematology (2015)
-
Neuromuscular complications after hematopoietic stem cell transplantation
Supportive Care in Cancer (2014)
-
Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
Bone Marrow Transplantation (2012)